课题基金 / 基金详情

TRIAL OF REPEATED DOSES OF LJP 394 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHMATOSUS

TRIAL OF REPEATED DOSES OF LJP 394 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHMATOSUS
在系统性红斑狼疮患者中重复服用 LJP 394 的试验
批准号:
6304188
负责人:
Rosalind Ramsey-Goldman
金额:
$2.05万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-12-01 至 2000-11-30

项目摘要

项目成果

Rosalind Ramsey-Goldman的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是确定LJP 394是否比安慰剂更有效地预防既往有狼疮性肾病病史的患者的肾耀斑。 这项多中心、双盲、随机、安慰剂对照研究将入组约400例患者,包括3个阶段:筛选/资格鉴定期、双盲、安慰剂对照治疗期和随访评估期。 这是一项为期18个月的试验,患者完成了61次访视。
英文摘要
The purpose of this study is to determine whether LJP 394 is more effective than placebo in preventing renal flare in patients with a prior history of lupus renal disease. This multicenter, double-blind, randomized, placebo-controlled study will enroll approximately 400 patients and is composed of three periods: a screening/qualifying period, a double-blind, placebo-controlled treatment period, and a follow-up assessment period. This is an 18 month trial, with patients completing 61 visits.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
  • 批准号:
    10654055
  • 项目类别:
  • 资助金额:
    $20.0万
  • 财政年份:
    2022
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Differentiating clinical characteristics between two subtypes of antiphosphatidylethanolamine
  • 批准号:
    10510394
  • 项目类别:
  • 资助金额:
    $24.0万
  • 财政年份:
    2022
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Cancer risk after renal transplant in autoimmune disease
  • 批准号:
    8387402
  • 项目类别:
  • 资助金额:
    $9.19万
  • 财政年份:
    2012
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
Cancer risk after renal transplant in autoimmune disease
  • 批准号:
    8507183
  • 项目类别:
  • 资助金额:
    $7.35万
  • 财政年份:
    2012
  • 负责人:
    Rosalind Ramsey-Goldman
  • 依托单位:
海外基金